Preventing HER2 degradation improves efficacy of trastuzumab deruxtecan

View at publisher
Authors: Gail D. Lewis Phillips
Cited by: 0
References: 15

Fields of Study & Subjects

HER2/EGFR in Cancer Research Lung Cancer Treatments and Mutations Protein Degradation and Inhibitors

Publication details

Journal / source
Nature Cancer
Volume
7
Issue
2
Pages
251–253
Publication date
29 January 2026
Language
EN